Here are relevant reports on : non-invasive-aesthetic-devices-market
-
Uterine Fibroid Treatment Devices Market by Technology (Ablation, Hysterectomy, Myomectomy Laparoscopy, Microwave, Cryoablation, HIFU, MRgFUS, Myolysis, Embolization), Mode of Treatment (Invasive, Minimally Invasive, Non-Invasive) - Global Forecasts to 2020
The global uterine fibroid treatment devices market is technologically diverse segment with presence of large number of players. The market offers significant growth opportunities in the next five years to major as well as new players that are aspiring to enter into this medical device segment. Over the past three years, leading players of the global uterine fibroid treatment devices market have adopted new product launches, establishing new manufacturing facilities, and strategic acquisitions as its key business strategies to ensure their positive growth in this market. As of 2014,
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Bariatric Surgery Devices Market by Device Type (Minimally Invasive (Stapling, Suturing, Vessel Sealing Devices), Non Invasive), Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Banding) & Region - Global Forecast to 2027
The global bariatric surgery devices market growth is primed to transition from $1.9 billion in 2022 to $2.4 billion by 2027, showcasing a strong CAGR of 5.4%. The market is driven by the increasing prevalence of obesity and associated comorbidities, which have led to a rise in bariatric surgeries. Key market dynamics include a growing preference for minimally invasive surgical devices due to their advantages such as fewer complications and faster recovery.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User & Region - Global Forecast to 2027
The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Bariatric Surgery Market by Devices (Assisting (Suturing, Closure), Implantable (Gastric Bands, Electrical Stimulation)), Procedure (Gastric Sleeve Surgery), Surgery (Invasive, Non-Invasive), End User (Clinics, Hospitals) - Global Forecast to 2022
The global bariatric surgery market is expected to reach USD 2.83 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 9.2% from 2018 to 2022. Prominent players in the bariatric surgery market are Ethicon US, LLC.(Johnson and Johnson) (US), Medtronic Plc (Ireland), B.Braun Melsungen AG (Germany), Olympus (Japan), Allergan Inc. (US), Intuitive Surgical, Inc. (US), Cook Medical (US), CONMED Corporation (US), Apollo Endosurgery, Inc. (US) , and Cousin Biotech (France).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
The blood flow measurement devices market is projected to grow at a CAGR of 9.2%. The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029
The global brain computer interface market, valued at US$235 million in 2023, stood at US$262 million in 2024 and is projected to advance at a resilient CAGR of 14.1% from 2024 to 2029, culminating in a forecasted valuation of US$506 million by the end of the period. The growth of this market is driven by the growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable brain computer interface devices, and rising Investments in research and development.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring Product (Pressure Guidewires, FFR Measurement Systems), Application, and Region - Global Forecasts to 2024
The fractional flow reserve market is projected to reach USD 1,082 million by 2024, at a CAGR of 16.0%. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR. The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
The global minimally invasive surgical instruments market, valued at US$29.9 billion in 2023, stood at US$31.7 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$49.9 billion by the end of the period. The growth of this market is primarily fueled by the rising prevalence of surgical procedures globally, the advantages of minimally invasive surgery over traditional open techniques, and the increasing use of advanced robotics in ambulatory surgical centers.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Food Intolerance Test Market by Test Type (Conventional (Skin (Scratch, Intradermal, Patch), Blood (Elisa, Rast)), Alternative Allergy (Non Invasive (Hair, Kinesiology), Invasive (Igg Blood, Electro-Dermal, Cytotoxic, Microarray))) - Global Forecast to 2020
Food intolerance is a non-allergic hypersensitivity to a food product. It is caused when an incompletely digested food enters into a bloodstream. It is usually either due to lack of required enzyme to digest food or inability to absorb a digested food. Food intolerance testing is needed to assess digestion capability and suggest appropriate diet.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
